• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疫苗接种政策中的决策支持。

Decision support in vaccination policies.

作者信息

Piso B, Wild C

机构信息

Ludwig Boltzmann Institute for Health Technology Assessment, Garnisongasse 7/20, 1090 Vienna, Austria.

出版信息

Vaccine. 2009 Oct 9;27(43):5923-8. doi: 10.1016/j.vaccine.2009.07.105. Epub 2009 Aug 19.

DOI:10.1016/j.vaccine.2009.07.105
PMID:19698809
Abstract

BACKGROUND

Looking across boarders reveals that the national immunization programs of various countries differ in their vaccination schedules and decisions regarding the implementation and funding of new vaccines. The aim of this review is to identify decision aids and crucial criteria for a rational decision-making process on vaccine introduction and to develop a theoretical framework for decision-making based on available literature.

METHODS

Systematic literature search supplemented by hand-search.

RESULTS

We identified five published decision aids for vaccine introduction and program planning in industrialized countries. Their comparison revealed an overall similarity with some differences in the approach as well as criteria. Burden of disease and vaccine characteristics play a key role in all decision aids, but authors vary in their views on the significance of cost-effectiveness analyses. Other relevant factors that should be considered before vaccine introduction are discussed to highly differing extents. These factors include the immunization program itself as well as its conformity with other programs, its feasibility, acceptability, and equity, as well as ethical, legal and political considerations. Assuming that the most comprehensive framework possible will not provide a feasible tool for decision-makers, we suggest a stepwise procedure.

CONCLUSIONS

Though even the best rational approach and most comprehensive evaluation is limited by remaining uncertainties, frameworks provide at least a structured approach to evaluate the various aspects of vaccine implementation decision-making. This process is essential in making consistently sound decisions and will facilitate the public's confidence in the decision and its realization.

摘要

背景

纵观各国情况可知,不同国家的国家免疫规划在疫苗接种时间表以及新疫苗实施和资金投入的决策方面存在差异。本综述的目的是确定在引入疫苗时进行合理决策过程的决策辅助工具和关键标准,并根据现有文献制定决策理论框架。

方法

系统文献检索辅以手工检索。

结果

我们确定了五份已发表的关于工业化国家疫苗引入和规划的决策辅助工具。对它们的比较显示,总体上有相似之处,但在方法和标准上存在一些差异。疾病负担和疫苗特性在所有决策辅助工具中都起着关键作用,但作者们对成本效益分析重要性的看法各不相同。在引入疫苗之前应考虑的其他相关因素,在讨论程度上差异很大。这些因素包括免疫规划本身及其与其他规划的一致性、可行性、可接受性和公平性,以及伦理、法律和政治方面的考虑。假设最全面的框架也无法为决策者提供可行工具,我们建议采用逐步程序。

结论

尽管即使是最佳的理性方法和最全面的评估也会受到剩余不确定性的限制,但框架至少提供了一种结构化方法来评估疫苗实施决策的各个方面。这一过程对于做出始终合理的决策至关重要,并将促进公众对决策及其实施的信心。

相似文献

1
Decision support in vaccination policies.疫苗接种政策中的决策支持。
Vaccine. 2009 Oct 9;27(43):5923-8. doi: 10.1016/j.vaccine.2009.07.105. Epub 2009 Aug 19.
2
New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.新型疫苗采用:七个中低收入国家国家决策过程的定性研究。
Health Policy Plan. 2012 May;27 Suppl 2:ii5-16. doi: 10.1093/heapol/czs035.
3
Developing a vaccination evaluation model to support evidence-based decision making on national immunization programs.
Vaccine. 2006 May 29;24(22):4769-78. doi: 10.1016/j.vaccine.2006.03.022. Epub 2006 Mar 27.
4
An analytical framework for immunization programs in Canada.加拿大免疫规划的分析框架。
Vaccine. 2005 Mar 31;23(19):2470-6. doi: 10.1016/j.vaccine.2004.10.029.
5
Criteria for inclusion of vaccinations in public programmes.纳入公共规划疫苗的标准。
Vaccine. 2010 Apr 9;28(17):2924-31. doi: 10.1016/j.vaccine.2010.02.021. Epub 2010 Feb 26.
6
Translational research to assist policy decisions about introducing new vaccines in developing countries.开展转化研究,以辅助做出有关在发展中国家引入新疫苗的政策决策。
J Health Popul Nutr. 2004 Sep;22(3):223-31.
7
Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.评估轮状病毒疫苗引入免疫规划后的效果及对公共卫生的影响。
J Infect Dis. 2009 Nov 1;200 Suppl 1:S291-9. doi: 10.1086/605059.
8
Using social network analysis to examine the decision-making process on new vaccine introduction in Nigeria.利用社交网络分析研究尼日利亚新疫苗引入决策过程。
Health Policy Plan. 2012 May;27 Suppl 2:ii27-38. doi: 10.1093/heapol/czs037.
9
The decision making process on new vaccines introduction in South Africa.南非引入新疫苗的决策过程。
Vaccine. 2012 Sep 7;30 Suppl 3:C9-13. doi: 10.1016/j.vaccine.2012.04.027.
10
The Supporting Independent Immunization and Vaccine Advisory Committees (SIVAC) initiative: a country-driven, multi-partner program to support evidence-based decision making.支持独立免疫和疫苗咨询委员会(SIVAC)倡议:一个由国家主导、多方合作伙伴参与的项目,旨在支持基于证据的决策制定。
Vaccine. 2010 Apr 19;28 Suppl 1:A26-30. doi: 10.1016/j.vaccine.2010.02.028.

引用本文的文献

1
Prioritization of Vaccines for Introduction in the National Immunization Program in the Republic of Korea.韩国国家免疫规划中拟引入疫苗的优先排序
Vaccines (Basel). 2024 Aug 4;12(8):886. doi: 10.3390/vaccines12080886.
2
Identifying factors that can be used to assess a country's readiness to deploy a new vaccine or improve uptake of an underutilised vaccine: a scoping review.确定可用于评估一个国家部署新疫苗或提高未充分利用疫苗接种率准备情况的因素:范围综述。
BMJ Open. 2024 May 7;14(5):e080370. doi: 10.1136/bmjopen-2023-080370.
3
Parents' and healthcare professionals' perception toward the introduction of a new fully liquid hexavalent vaccine in the Malaysian national immunization program: a cross-sectional study instrument development and its application.
家长和医疗保健专业人员对马来西亚国家免疫计划中引入新型全液体六价疫苗的看法:横断面研究工具的开发及其应用。
Front Immunol. 2023 Apr 27;14:1052450. doi: 10.3389/fimmu.2023.1052450. eCollection 2023.
4
Identifying Attributes for a Value Assessment Framework in China: A Qualitative Study.在中国建立价值评估框架的属性识别:一项定性研究。
Pharmacoeconomics. 2023 Apr;41(4):439-455. doi: 10.1007/s40273-022-01235-6. Epub 2023 Feb 2.
5
WICID framework version 1.0: criteria and considerations to guide evidence-informed decision-making on non-pharmacological interventions targeting COVID-19.WICID 框架 1.0 版:指导针对 COVID-19 的非药物干预措施进行循证决策的标准和考虑因素。
BMJ Glob Health. 2020 Nov;5(11). doi: 10.1136/bmjgh-2020-003699.
6
Development of the WHO-INTEGRATE evidence-to-decision framework: an overview of systematic reviews of decision criteria for health decision-making.世界卫生组织综合证据到决策框架的制定:健康决策制定决策标准系统评价概述
Cost Eff Resour Alloc. 2020 Feb 11;18:8. doi: 10.1186/s12962-020-0203-6. eCollection 2020.
7
The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review.HIV疫苗的潜在成本效益:一项系统综述。
Pharmacoecon Open. 2017 Mar;1(1):1-12. doi: 10.1007/s41669-016-0009-9. Epub 2017 Jan 30.
8
Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community.疫苗健康经济评估方法与免疫决策框架:欧洲疫苗经济学共同体的共识框架
Pharmacoeconomics. 2016 Mar;34(3):227-44. doi: 10.1007/s40273-015-0335-2.
9
Stakeholders' perception on including broader economic impact of vaccines in economic evaluations in low and middle income countries: a mixed methods study.利益相关者对将疫苗在低收入和中等收入国家的更广泛经济影响纳入经济评估的看法:一项混合方法研究。
BMC Public Health. 2015 Apr 10;15:356. doi: 10.1186/s12889-015-1638-0.
10
Health and economic outcomes of introducing the new MenB vaccine (Bexsero) into the Italian routine infant immunisation programme.将新型B型脑膜炎球菌疫苗(Bexsero)引入意大利常规婴儿免疫规划的健康和经济结果。
PLoS One. 2015 Apr 13;10(4):e0123383. doi: 10.1371/journal.pone.0123383. eCollection 2015.